Ready-to-print and ready-to-seed into your biofabrication application. RoosterRTP™-hBM-50M-XF are xeno-free formulated (XFF) late passage hBM-MSCs that are translation-friendly, clinically-relevant, and intended to be thawed and used in a research setting. They are not intended for further expansion or banking. RoosterRTP-hBM-50M-XF are expanded using controlled manufacturing processes from a Master Cell Bank for 4 passages to a PDL of 15-17, and then harvested, formulated, filled, and cryopreserved. As reported in the accompanying QC Brief, these cells maintain the critical MSC quality attributes at late-passage of the parental cell lot (cell surface marker expression, trilineage differentiation, immunomodulatory potential (IDO assay), and angiogenic cytokine secretion). This ready-to-use critical raw material enables product developers and researchers to forgo the cell manufacturing process, skipping cell culture altogether.
Product Features
50 million late-passage (PDL 15-17) cryopreserved hBM-MSCs
Xeno-free formulation (XFF)
No culture required. Not intended for further subculturing and banking.
Minimize time between experiments for accelerated discovery
Rapidly prototype tissue designs
Add as the cell component of bioink
Seed directly into tissue engineered scaffolds, or incorporate within a medical device
Readily study biomaterial and biofabrication effects on tri-lineage differentiation, cytokine secretion profile, and inducible immunomodulatory function
Industry-leading functional characterization
Preserved critical MSC quality attributes at late-passage
Comparable to parent lot
Manufactured with scalable processes & cryopreserved using standard, controlled processes
Lots released based on viability, plating efficiency, and sterility
